A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including ...

Study shows diabetes drugs' potential beyond weight loss A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including dementia and ...

A major new study has highlighted significant health risks associated with popular weight loss injections such as Ozempic, ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat substance abuse disorders, psychosis, infections, cancer, and dementia.

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study ...

A study analyzing data from over 2 million veterans found that GLP-1 receptor agonists, popular weight-loss drugs like Ozempic and Wegovy, provide significant neurological and behavioral health ...

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

While weight-loss drugs were linked to lower risk of some conditions, they were also associated with some adverse health ...

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.